Search results for Pharma Stock

Latest updates for Pharma Stock

Fresh curated links around Pharma stock are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

tradebrains.in /1 month ago

Pharma Stock in Focus After Receiving USFDA Approval for Benzonatate Capsules

Synopsis: The shares of this company rose 8.9 percent following a press release announcing USFDA approval for its Benzonatate Capsules, boosting investor confidence. The share of t...

Read source

tradebrains.in /2 weeks ago

Healthcare Stock Surges 11% on Strong ANDA Pipeline and 385% Branded Generics Growth in Q4

Synopsis: The share jumps 11 percent on strong Q4 performance, driven by robust ANDA (Abbreviated New Drug Application) pipeline and 385 percent growth in branded generics, signall...

Read source

tradebrains.in /1 month ago

Pharma Stock in Focus After Board Approves Buyback of Shares Worth ₹800 Cr

Synopsis: The Hyderabad-based pharma giant has given the green light to repurchase shares at ₹1,475 each, a 10% premium over the current market price. A major Indian pharma giant...

Read source

tradebrains.in /1 month ago

300% Dividend: Pharma Stock Skyrockets 12% After Announcing Q4 Results

Synopsis: RPG Life Sciences reported mixed quarterly numbers, with strong revenue growth but a sharp decline in reported profit due to base effects from last year’s one-time gain....

Read source

tradebrains.in /1 week ago

Hidden Gem: Pharma Stock That Has Entered The US Govt Drug Supply Market

Synopsis: Senores Pharmaceuticals is quietly building a larger global pharma platform with the US at the centre of its growth plan. Backed by a rising ANDA portfolio, acquisitions,...

Read source

tradebrains.in /1 month ago

Pharma Stock Jumps After Receiving Approval for 2 Cancer-Related Bone Medicines

Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...

Read source

tradebrains.in /1 day ago

20% Upper Circuit: Pharma Stock Skyrockets After Announcing Strong Q4 Earnings

Synopsis: The share of this pharma company hit a 20 percent upper circuit after strong Q4 FY26 earnings driven by anesthetic demand, robust margins, and export-led growth momentum....

Read source

tradebrains.in /1 month ago

Pharma Stock Jumps After Receiving Approval for 2 Medicines from Health Canada

Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...

Read source

tradebrains.in /2 weeks ago

Pharma Stock Jumps 5% After Announcing Acquisition of Nasdaq-Listed Pharma Firm for ₹1,600 Cr

Synopsis: A leading pharma group expands its US specialty oncology footprint through an all-cash buyout of a Nasdaq-listed firm with an approved cancer supportive-care drug. The In...

Read source

tradebrains.in /2 days ago

Pharma Stock to Buy Now for 25% Upside Potential; Recommended by Goldman Sachs

Synopsis: Aurobindo Pharma drew brokerage attention after strong Europe-led growth and steady Q4 FY26 performance, with analysts highlighting margin stability and positive medium-t...

Read source

tradebrains.in /1 month ago

Fundamentally Strong Pharma Stock Trading at a Discount of 34% to Keep an Eye On

Synopsis: Caplin Point Laboratories Limited, a small-cap pharma firm, is trading at a 34.36% discount from its 52-week high, attracting attention due to consistent growth, strong r...

Read source

businesstoday.in /1 week ago

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Read source

tradebrains.in /1 month ago

Specialty Pharma Hits 5% Following International Distribution Order Worth $1.5 Million

Synopsis:- Speciality Medicines Limited, listed on BSE-SME just 23 days ago, has announced a commercial distribution arrangement with an unnamed international entity for pharmaceut...

Read source

tradebrains.in /4 weeks ago

₹94 Pharma-Chemical Stock: Global Ibuprofen Leader With New API Expansion Plans

Synopsis: This Pharma-Chemical stock is a global Ibuprofen leader with a large integrated manufacturing base, low debt and new API expansion plans. But the bigger question is wheth...

Read source

valueresearchonline.com /1 month ago

India's pharma space has a new contender. Worth chasing?

Acutaas doubled revenue and pushed margins to 29 per cent in two years. But at 60 times earnings, the stock is already priced as though its CDMO transformation is complete.

Read source

businesstoday.in /1 week ago

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

Read source

tradebrains.in /1 week ago

Pharma Stock Hits 5% Upper Circuit After Board Approves SME-to-Main Board Migration

Synopsis: Pharma stock hit a 5% upper circuit after approving migration from BSE SME to BSE Main Board and filing for NSE Main Board listing, and has initiated a postal ballot to s...

Read source

tradebrains.in /1 month ago

Pharma Stock in Focus After Board Sets Record Date for 1:5 Stock Split and 1:1 Bonus Issue

Synopsis: Anlon Healthcare Limited set Friday, April 24, 2026, as the record date to determine eligible shareholders for its 1:5 stock split and 1:1 bonus issue. This Micro-cap Pha...

Read source

tradebrains.in /4 weeks ago

2 Stocks Riding the $100 Billion GLP-1 Weight-Loss Wave in India

Synopsis: The global obesity drug boom is minting winners in unexpected places. As pharma giants race to supply GLP-1 therapies, two Indian manufacturers one making the device, ano...

Read source

economictimes.indiatimes.com /3 weeks ago

Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid drag

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lost Revlimid sales and pricing challenges....

Read source

fool.com /1 week ago

The Most Important Healthcare Stock You're Not Watching

Down more than 50% from its 2021 highs, this pharmaceutical giant has been forgotten by Wall Street.

Read source

fool.com /1 month ago

Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?

This particular player has seen its yield rise in recent years.

Read source

tradebrains.in /4 weeks ago

Dr. Reddy’s: Nomura’s Analysis of the Pharma Stock, Does the Future Look Promising?

Synopsis: Nomura sees about 21 percent upside in Dr Reddy’s, driven by early generic entry, a $1 billion opportunity, and biosimilar pipeline, despite near-term margin pressure and...

Read source

tradebrains.in /1 month ago

Pharma stock jumps 9% after signing $11.75 Bil deal to acquire US-based firm

Synopsis:- Sun Pharmaceutical Industries has signed a definitive agreement to acquire Organon & Co. for $14 per share in an all-cash deal worth $11.75 billion in enterprise val...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.